For adults with moderately to severely active rheumatoid arthritis in combination with methotrexate
REMICADE® is given through a needle placed in a vein (IV or intravenous infusion) in your arm.
REMICADE® infusion is given by a
trained healthcare professional
REMICADE® is given over a period
of about 2 hours
3 starter doses
at Weeks 0, 2, and 6
After starter doses, 1 maintenance
dose is infused every 8 weeks*
*Your doctor can also adjust the dosage and/or dosing schedule if you are still experiencing joint symptoms. If your dosage is increased, it is important to talk with your doctor about the increased possibility of infection.
Your doctor’s office or infusion center will schedule your appointments. If you need to reschedule an appointment, call your doctor’s office or infusion provider.
For detailed information about the REMICADE® infusion process and questions, please talk to your doctor.
BEFORE YOU ARRIVE
DRINK UP!
It’s a good idea to show up to your infusion well hydrated.
PACK UP!
REMICADE® is administered over a period of about 2 hours.
Bring a book, laptop, tablet, or other digital device…or just a pillow to take a nap to pass the time.
DRESS UP!
It’s important to dress for the occasion. Make comfort a priority: wear loose-fitting clothing and layers in case you get too warm or too cold.
DURING YOUR IV INFUSION
When you arrive, your healthcare professional will check your vital signs, ask you questions about your overall health, and provide you with the Medication Guide to read before each infusion.
A healthcare professional will determine the right amount of medication for you based on your weight and will be there to give you your treatment. Your doctor may decide to give you other medications before starting the REMICADE® infusion to prevent or lessen
A healthcare professional will check in with you during your infusion. The infusion is given over a period of about 2 hours.
AFTER YOUR IV INFUSION
You will be monitored at the doctor’s office or infusion center for a period of time afterward just to make sure you are not having a reaction, and then you will be free to leave. You should be able to continue your normal schedule, as advised by your doctor.
Gather your medical history and a list of your current medications to bring with you to your infusion appointment.
Some doctors offer IV infusion services on-site. If your doctor’s office doesn’t, it’s easy to find an infusion center near you.
Visit 2infuse.com to find treatment locations that are close to your home or workplace.
At Janssen, we don't want cost to get in the way of treatment you need. Once you and your doctor have decided REMICADE® is right for you, we can help you explore options to lower your out-of-pocket cost for REMICADE®.
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections which include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body or caused infections in certain areas (such as skin). Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking tumor necrosis factor (TNF) blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in male teenagers or young men with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
It is not known if REMICADE® is safe and effective in children under 6 years of age.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
The more common side effects of REMICADE® include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.
Please read the full Prescribing Information and Medication Guide for REMICADE® and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-53017v3
REMICADE® is a prescription medication used to treat:
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Plaque Psoriasis
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections which include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body or caused infections in certain areas (such as skin). Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking tumor necrosis factor (TNF) blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in male teenagers or young men with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
It is not known if REMICADE® is safe and effective in children under 6 years of age.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
The more common side effects of REMICADE® include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.
Please read the full Prescribing Information and Medication Guide for REMICADE® and discuss any questions you have with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
cp-53017v3
REMICADE® is a prescription medication used to treat:
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Rheumatoid Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Plaque Psoriasis